• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A micro-assay for estrogen receptor in breast tumor with use of 125I-labeled estradiol.

作者信息

Van N T, Fritsche H A, Trujillo J M

出版信息

Clin Chem. 1982 Jun;28(6):1303-8.

PMID:7074937
Abstract

The concentration of estrogen receptor protein in breast-tumor tissue is generally expressed in units of femtomoles of estradiol bound by the receptor per milligram of cytosol protein. The sensitivity of the estrogen receptor radioligand assay is therefore related to the specific activity of the steroid label used for the binding assay, the amount of the receptor protein in the volume of cytosol used, and the protein concentration in the cytosol. In this paper, we discuss factors affecting the sensitivity of the estrogen receptor assay and present various approaches for optimizing the assay. We also describe a procedure that involves a radioiodinated estradiol of high specific activity, a micro-technique for preparing tumor cytosol, and a micro-assay procedure with which the estrogen receptor protein can be measured in as little as 50 mg (wet weight) of tissue.

摘要

相似文献

1
A micro-assay for estrogen receptor in breast tumor with use of 125I-labeled estradiol.
Clin Chem. 1982 Jun;28(6):1303-8.
2
Simultaneous measurement of estrogen and progesterone receptors in tumor cytosols with use of 125I-labeled estradiol and of 3H-R5020.
Clin Chem. 1981 May;27(5):687-91.
3
A double-labeling assay for simultaneous estimation and characterization of estrogen and progesterone receptors using radioiodinated estradiol and tritiated Org 2058.一种使用放射性碘化雌二醇和氚标记的Org 2058同时估计和表征雌激素受体与孕激素受体的双标记测定法。
Tumori. 1986 Jun 30;72(3):251-7. doi: 10.1177/030089168607200305.
4
Three radioligands compared for determining cytoplasmic estrogen-receptor content of human breast carcinomas.
Clin Chem. 1982 Mar;28(3):532-7.
5
[Measurement of cytosol estrogen receptor in human breast cancer using 16 alpha-125I-estradiol].[应用16α-125I-雌二醇测定人乳腺癌胞浆雌激素受体]
Kaku Igaku. 1987 Mar;24(3):327-33.
6
Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors.人乳腺肿瘤中雌激素受体免疫细胞化学检测与类固醇结合检测的比较
Cancer Res. 1985 Jan;45(1):293-304.
7
Criteria for the establishment of a double-labeling assay for simultaneous determination of estrogen and progesterone receptors.
Oncology. 1984;41(1):25-32. doi: 10.1159/000225785.
8
Characteristics of the dextran-coated charcoal assay for estradiol receptor in breast cancer preparations.乳腺癌制剂中雌二醇受体葡聚糖包被活性炭测定法的特点。
J Lab Clin Med. 1979 Nov;94(5):784-98.
9
Limitation of immunohistochemical localization of estrogen receptor.雌激素受体免疫组织化学定位的局限性。
J Surg Oncol. 1986 Oct;33(2):88-91. doi: 10.1002/jso.2930330206.
10
Improvement of routine estrogen and progesterone assay: double labeling with 125-I-labeled estradiol and [3H]R5020.常规雌激素和孕酮检测方法的改进:用125-I标记的雌二醇和[3H]R5020进行双重标记
Clin Chem. 1982 Mar;28(3):552-3.